About Us
Founded in 2021, Genpax is committed to advancing the world’s knowledge of bacterial pathogens by developing the most advanced suite of bacterial whole genome sequencing analytical tools and resources.
Press releases
Whole Genome Sequencing Can Transform the Management of...
An economic model by bioinformatics company Genpax published in Microbial Genomics concludes that in England the National Health Service (NHS)... read more
22.08.2023 • By Genpax